Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1978-06-02
1979-06-26
Ford, John M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
544 8, C07D28534, A01N 912
Patent
active
041593286
ABSTRACT:
A tetrahydro-1,3,5-thiadiazin-4-one represented by the general formula, ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3, which may be the same or different, represent each an alkyl group, allyl group, cycloalkyl group, alkoxyalkyl group, benzyl group, phenyl group or substituted phenyl group having as substituents alkyl groups, nitro group, halogen atoms, alkoxy groups, or trifluoromethyl group and R.sup.2 and R.sup.3 may also represent hydrogen atoms, is a new compound and useful for controlling insects and mites.
REFERENCES:
patent: 3741964 (1973-06-01), Chupp
Chupp, J. of Heterocyclic Chemistry, vol. 8, pp. 677-679 (1971).
Tsuge et al., Bull. Chemical Soc., Japan, vol. 45, pp. 2877-2882 (1972).
Harada Tatsuo
Ikeda Kenichi
Kanno Hideo
Yasui Michihiro
Ford John M.
Nihon Nohyaku Co. Ltd.
LandOfFree
Tetrahydro-1,3,5-thiadiazin-4-one derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydro-1,3,5-thiadiazin-4-one derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydro-1,3,5-thiadiazin-4-one derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1558662